Experts on diabetes provide insights gleaned from the SIMPLE study and outline patient factors that inform treatment decisions.
Real-Time CGM Reduces Risk of Large Newborns in Gestational Diabetes: Daily Dose
Your daily dose of the clinical news you may have missed.
Obesity & Type 2 Diabetes: An Expert Discussion
In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.
Lilly's Novel Oral GLP-1 Orforglipron Shows Superior Efficacy in 2 Phase 3 Trials
Topline phase 3 data shows oral GLP-1 cuts HbA1c by 2.1% when added to basal insulin, nearly triple placebo's effect in patients poorly controlled on current therapy.
Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD.
Approximately Half of People with Diabetes Worldwide Unaware They Have the Disease: Daily Dose
Novo Nordisk Resubmits Insulin Icodec Injection to FDA for Potential First Once-Weekly Basal Insulin Therapy for T2D
Novo Nordisk aims to revolutionize diabetes care with its resubmission for insulin icodec, a potential first once-weekly basal insulin for type 2 diabetes therapy in adults.